9 Meters Biopharma, Inc. is a clinical-stage biopharmaceutical company, which focuses on unmet needs in gastroenterology. The company is headquartered in Raleigh, North Carolina and currently employs 10 full-time employees. The company went IPO on 2016-07-08. The firm has filed a voluntary petition for relief under provisions of Chapter 7 of Title 11 of the United States Code (the Bankruptcy Code) in the United States Bankruptcy Court for the Eastern District of North Carolina.
Leveraging in-depth analyst evaluations, we have synthesized key insights from expert assessments to present a positive outlook for NMTRQ. Analysts highlight solid fundamentals and favorable market sentiment, suggesting upside potential in the near term. Based on this thorough expert analysis, we maintain an optimistic view of this stock. Our conclusion: NMTRQ is a Buy candidate.
NMTRQ stock price ended at $0 on 星期五, after rising NaN%
On the latest trading day Apr 24, 2026, the stock price of NMTRQ rose by NaN%, climbing from $0.00 to $0.00. Throughout the session, the stock experienced a volatility of NaN%, with prices fluctuating between a daily low of $0.00 and a high of $0.00. Alongside this price increase, trading volume also rose by 2.4K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 367 shares were traded, amounting to a market value of approximately --.